Dr Cosgrove on the FDA Approval of Mirvetuximab Soravtansine for Frα+ Ovarian Cancer onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.
Zangmeister Cancer Center to provide enhanced gynecologic oncology services to its patients through a collaboration with university physicians. COLUMBUS, Ohio, December 18, 2023.